Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eur J Ophthalmol ; 31(4): 1584-1587, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33631984

RESUMO

PURPOSE: Ocular features of Alport syndrome include anterior lenticonus, posterior polymorphous corneal dystrophy, and fleck-and-dot retinopathy in most cases. Keratoconus in such patients has been rarely mentioned in previous studies. To our knowledge, this is the first report of corneal cross-linking for halting the progression of keratoconus in a patient with Alport syndrome. CASE REPORT: A 22-year-old male was referred for his initial corneal topography, after he was already prescribed with rigid gas-permeable contact lenses. Alport syndrome was diagnosed in his infancy and gene COL4A5 mutation was confirmed. Ophthalmological evaluation confirmed keratoconus. One-year follow-up showed a progression on his right eye and standard corneal cross-linking was performed. Stabilization of the disease marked by normalization in visual function and corneal tomography values was noticed 1 year after the procedure. CONCLUSIONS: When diagnosing ocular clinical findings of Alport syndrome, keratoconus should be considered. Standard corneal cross-linking protocol can halt its progression.


Assuntos
Distrofias Hereditárias da Córnea , Ceratocone , Nefrite Hereditária , Fotoquimioterapia , Adulto , Córnea , Distrofias Hereditárias da Córnea/diagnóstico , Distrofias Hereditárias da Córnea/tratamento farmacológico , Topografia da Córnea , Reagentes de Ligações Cruzadas/uso terapêutico , Humanos , Ceratocone/diagnóstico , Ceratocone/tratamento farmacológico , Masculino , Nefrite Hereditária/complicações , Nefrite Hereditária/diagnóstico , Nefrite Hereditária/tratamento farmacológico , Fármacos Fotossensibilizantes/uso terapêutico , Riboflavina/uso terapêutico , Raios Ultravioleta , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA